Growth hormone secretagogues and hypothalamic networks Marie-Thérèse Bluet-PajotVirginie TolleClaude Kordon OriginalPaper Pages: 1 - 8
Growth hormone secretagogue receptor family members and ligands Roy G. SmithReid LeonardAndrew Howard OriginalPaper Pages: 9 - 14
Central actions of the nonpeptide growth hormone secretagogue GHS-25 Alex R. T. BaileyLouise GilliverRoy G. Smith OriginalPaper Pages: 15 - 19
Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin Gloria Shaffer TannenbaumCyril Y. Bowers OriginalPaper Pages: 21 - 27
Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland Romano DeghenghiMauro PapottiVittorio Locatelli OriginalPaper Pages: 29 - 33
Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands Emanuela ArvatLaura GianottiRomano Deghenghi OriginalPaper Pages: 35 - 43
Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2 Johannes D. VeldhuisWilliam S. EvansStacey Anderson OriginalPaper Pages: 45 - 62
Effects of growth hormone and its secretagogues on bone Johan SvenssonSabrina LallJohn-Olov Jansson OriginalPaper Pages: 63 - 66
Synthetic growth hormone secretagogues control growth hormone secretion in the chicken at pituitary and hypothalamic levels Kris L. GerisGerry J. HickeyVeerle M. Darras OriginalPaper Pages: 67 - 72
The in vitro effect of leptin on growth hormone secretion from primary cultured ovine somatotrophs Chen ChenSang-Gun RohArieh Gertler OriginalPaper Pages: 73 - 78
Growth hormone/insulin-like growth factor1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1–44 NH2 and in combination in older men and women with decreased growth hormone secretion C. Y. BowersR. Granda-Ayala OriginalPaper Pages: 79 - 86
Biologic activities of growth hormone secretagogues in humans Ezio GhigoEmanuela ArvatFranco Camanni OriginalPaper Pages: 87 - 93
Growth hormone secretagogues as diagnostic tools in disease states Roberto BaldelliXose L. OteroFelipe F. Casanueva OriginalPaper Pages: 95 - 99
Presence of ghrelin in normal and adenomatous human pituitary Márta KorbonitsMasayasu KojimaAshley B. Grossman OriginalPaper Pages: 101 - 104
Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy Fabio BroglioAndrea BensoEzio Ghigo OriginalPaper Pages: 105 - 108
Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment Antonio TorselloGiuseppe RossoniFerruccio Berti OriginalPaper Pages: 109 - 112
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death Nicoletta FilighedduAlberto FubiniAndrea Graziani OriginalPaper Pages: 113 - 119
Preclinical pharmacology of CP-424,391, and orally active pyrazolinone-piperidine growth hormone secretagogue Lydia C. PanPhilip A. CarpinoDavid D. Thompson OriginalPaper Pages: 121 - 132
Do growth hormone-releasing peptides act as ghrelin secretagogues? Ian Ahnfelt-RønneJette NowakUffe B. Olsen OriginalPaper Pages: 133 - 135